Esmaeil Mortaz, Mehrnaz Movassaghi, Ali Bassir, Neda K Dezfuli, Neda Dalil Roofchayee, Hamidreza Jamaati, Johan Garssen, Ian M Adcock
{"title":"Evaluation of Myeloid-derived Suppressor Cells in the Blood of Iranian COVID-19 Patients.","authors":"Esmaeil Mortaz, Mehrnaz Movassaghi, Ali Bassir, Neda K Dezfuli, Neda Dalil Roofchayee, Hamidreza Jamaati, Johan Garssen, Ian M Adcock","doi":"10.18502/ijaai.v21i4.10294","DOIUrl":null,"url":null,"abstract":"<p><p>The cytokine storm and lymphopenia are reported in coronavirus disease 2019 (COVID-19). Myeloid-derived suppressive cells (MDSCs) exist in two different forms, granulocyte (G-MDSCs) and monocytic (M-MDSCs), that both suppress T-cell function. In COVID-19, the role of chemokines such as interleukin (IL)-8 in recruiting MDSCs is unclear. A recent report has correlated IL-8 and MDSCs with poor clinical outcomes in melanoma patients. In the current study, we evaluated the frequency of MDSCs and their correlation with serum IL-8 levels in severe COVID-19 patients from Iran. Thirty-seven severe patients (8 on ventilation, 29 without ventilation), thirteen moderate COVID-19 patients, and eight healthy subjects participated in this study between 10th April 2020 and 9th March 2021. Clinical and biochemical features, serum, and whole blood were obtained. CD14, CD15, CD11b, and HLA-DR expression on MDSCs was measured by flow cytometry. COVID-19 patients compared to healthy subjects had a greater frequency of M-MDSCs (12.7±13.3% vs 0.19±0.20%,), G-MDSCs (15.8±12.6% vs 0.35±0.40%,) and total-MDSCs (27.5±17.3% vs 0.55±0.41%,). M-MDSC (16.8±15.8% vs 5.4±4.8%,) and total-MDSC (33.3±18.5% vs 17.3±13.3%) frequency was higher in non- ventilated compared to moderate COVID-19 subjects. Serum IL-8 levels were higher in patients with COVID-19 than in normal healthy subjects (6.4±7.8 vs. 0.10±00 pg/mL). Ventilated patients (15.7±6.7 pg/mL), non-ventilated patients (5.7±2.7 pg/mL) and moderate patients (2.8±3.0 pg/mL) had significantly different levels of IL-8. A negative correlation was found between the frequency of G-MDSCs and the international normalized ratio (INR) test (r=-0.39), and between the frequency of total-MDSCs and oxygen saturation (%) (r=-0.39). COVID-19 patients with severe non-ventilated disease had the highest levels of M-MDSCs. In addition to systemic MDSCs, lung, serum IL-8, and other inflammatory biomarkers should be measured.</p>","PeriodicalId":14560,"journal":{"name":"Iranian journal of allergy, asthma, and immunology","volume":null,"pages":null},"PeriodicalIF":1.2000,"publicationDate":"2022-08-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Iranian journal of allergy, asthma, and immunology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.18502/ijaai.v21i4.10294","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"ALLERGY","Score":null,"Total":0}
引用次数: 1
Abstract
The cytokine storm and lymphopenia are reported in coronavirus disease 2019 (COVID-19). Myeloid-derived suppressive cells (MDSCs) exist in two different forms, granulocyte (G-MDSCs) and monocytic (M-MDSCs), that both suppress T-cell function. In COVID-19, the role of chemokines such as interleukin (IL)-8 in recruiting MDSCs is unclear. A recent report has correlated IL-8 and MDSCs with poor clinical outcomes in melanoma patients. In the current study, we evaluated the frequency of MDSCs and their correlation with serum IL-8 levels in severe COVID-19 patients from Iran. Thirty-seven severe patients (8 on ventilation, 29 without ventilation), thirteen moderate COVID-19 patients, and eight healthy subjects participated in this study between 10th April 2020 and 9th March 2021. Clinical and biochemical features, serum, and whole blood were obtained. CD14, CD15, CD11b, and HLA-DR expression on MDSCs was measured by flow cytometry. COVID-19 patients compared to healthy subjects had a greater frequency of M-MDSCs (12.7±13.3% vs 0.19±0.20%,), G-MDSCs (15.8±12.6% vs 0.35±0.40%,) and total-MDSCs (27.5±17.3% vs 0.55±0.41%,). M-MDSC (16.8±15.8% vs 5.4±4.8%,) and total-MDSC (33.3±18.5% vs 17.3±13.3%) frequency was higher in non- ventilated compared to moderate COVID-19 subjects. Serum IL-8 levels were higher in patients with COVID-19 than in normal healthy subjects (6.4±7.8 vs. 0.10±00 pg/mL). Ventilated patients (15.7±6.7 pg/mL), non-ventilated patients (5.7±2.7 pg/mL) and moderate patients (2.8±3.0 pg/mL) had significantly different levels of IL-8. A negative correlation was found between the frequency of G-MDSCs and the international normalized ratio (INR) test (r=-0.39), and between the frequency of total-MDSCs and oxygen saturation (%) (r=-0.39). COVID-19 patients with severe non-ventilated disease had the highest levels of M-MDSCs. In addition to systemic MDSCs, lung, serum IL-8, and other inflammatory biomarkers should be measured.
2019冠状病毒病(COVID-19)报告了细胞因子风暴和淋巴细胞减少。髓源性抑制细胞(MDSCs)存在两种不同的形式,粒细胞(G-MDSCs)和单核细胞(M-MDSCs),两者都抑制t细胞功能。在COVID-19中,趋化因子如白细胞介素(IL)-8在募集MDSCs中的作用尚不清楚。最近的一份报告将IL-8和MDSCs与黑色素瘤患者的不良临床结果联系起来。在本研究中,我们评估了来自伊朗的重症COVID-19患者中MDSCs的频率及其与血清IL-8水平的相关性。2020年4月10日至2021年3月9日,37例重症患者(8例通气,29例不通气)、13例中度COVID-19患者和8例健康受试者参加了本研究。获得临床及生化特征、血清及全血。流式细胞术检测MDSCs中CD14、CD15、CD11b和HLA-DR的表达。与健康受试者相比,COVID-19患者的M-MDSCs(12.7±13.3% vs 0.19±0.20%)、G-MDSCs(15.8±12.6% vs 0.35±0.40%)和total-MDSCs(27.5±17.3% vs 0.55±0.41%)出现频率更高。非通气组M-MDSC(16.8±15.8% vs 5.4±4.8%)和total-MDSC(33.3±18.5% vs 17.3±13.3%)频率高于中度COVID-19受试者。新冠肺炎患者血清IL-8水平高于正常健康人(6.4±7.8 vs 0.10±00 pg/mL)。通气组(15.7±6.7 pg/mL)、非通气组(5.7±2.7 pg/mL)、中度通气组(2.8±3.0 pg/mL) IL-8水平差异有统计学意义。G-MDSCs出现频率与国际归一化比率(INR)检测呈负相关(r=-0.39),总mdscs出现频率与血氧饱和度(%)呈负相关(r=-0.39)。重症非通气疾病患者M-MDSCs水平最高。除了全身MDSCs外,还应测量肺、血清IL-8和其他炎症生物标志物。
期刊介绍:
The Iranian Journal of Allergy, Asthma and Immunology (IJAAI), an international peer-reviewed scientific and research journal, seeks to publish original papers, selected review articles, case-based reviews, and other articles of special interest related to the fields of asthma, allergy and immunology. The journal is an official publication of the Iranian Society of Asthma and Allergy (ISAA), which is supported by the Immunology, Asthma and Allergy Research Institute (IAARI) and published by Tehran University of Medical Sciences (TUMS). The journal seeks to provide its readers with the highest quality materials published through a process of careful peer reviews and editorial comments. All papers are published in English.